health ๐ฌ Long-term SpA therapy not linked to cancer risk
Extended use of targeted therapies for spondyloarthritis has not shown an elevated cancer risk in a large French cohort. This study involved over 56,000 adults with SpA, including psoriatic and axial subtypes, who started treatment between January 2014 and September 2022. The cohort tracked 1,224 cancers over a median follow-up of 5.0 years, assessing exposure annually. More than six months of annual exposure was linked to a lower risk of overall cancer, specifically haematological malignancies. These results offer reassurance for ongoing treatment decisions for patients with this condition. ๐ฌ